Abstract
Objectives
Premature ovarian insufficiency (POI) affects 1 in 10,000 children, with its molecular causes largely unknown. Adult studies suggest that low androgen levels induce ovarian insufficiency, but data on about this in children is limited. This study aims to assess the prevalence of low androgen levels in childhood POI and its relationship with adrenal insufficiency.
Methods
Idiopathic POI adolescents were categorized into two groups based on DHEAS and total testosterone (TT) measured by chemiluminescence. Low androgen group (LAG) was defined using cut-offs according to Tanner pubarche staging. Demographic, clinical, and laboratory data were compared. Morning cortisol <7 μg/dL and/or ACTH >96 or <5 pg/mL were planned to undergo ACTH stimulation testing, with a peak cortisol response <18 μg/dL considered insufficient.
Results
Forty-three adolescents, mean age 15.5 ± 1.3 years with a 46, XX karyotype, normal FMR1 mutation, FSH levels >40 mIU/mL, and low AMH levels were included. In 14 cases (37.8 %), DHEAS and TT were low. In the LAG, pubarche was absent in seven patients, and initial height SDS was significantly lower. Morning cortisol ranged from 7.9 to 23.5 μg/dL, with an ACTH of 29.4 ± 9.7 pg/mL. No differences in adrenal steroids or correlations between DHEAS and ACTH were observed.
Conclusions
Diminished androgen levels are prevalent in children with idiopathic POI. The potential for this condition to increase the risk of adrenal insufficiency and its impact on secondary ovarian insufficiency remains unclear. This study, the first of its kind in children, underscores the potential role of genetic factors in zona reticularis and ovarian development.
-
Research ethics: The local Institutional Review Board deemed the study exempt from review.
-
Informed consent: Not applicable.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: The authors state no conflict of interest.
-
Research funding: None declared.
-
Data availability: Not applicable.
References
1. Michala, L, Stefanaki, K, Loutradis, D. Premature ovarian insufficiency in adolescence: a chance for early diagnosis? Hormones 2020;19:277–83. https://doi.org/10.1007/s42000-019-00141-5.Search in Google Scholar PubMed
2. McGlacken-Byrne, SM, Conway, GS. Premature ovarian insufficiency. Best Pract Res Clin Obstet Gynaecol 2022;81:98–110. https://doi.org/10.1016/j.bpobgyn.2021.09.011.Search in Google Scholar PubMed
3. Nelson, LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606–14. https://doi.org/10.1056/nejmcp0808697.Search in Google Scholar PubMed PubMed Central
4. Geckinli, BB, Toksoy, G, Sayar, C, Soylemez, MA, Yesil, G, Aydın, H, et al.. Prevalence of X-aneuploidies, X-structural abnormalities, and 46, XY sex reversal in Turkish women with primary amenorrhea or premature ovarian insufficiency. Eur J Obstet Gynecol Reprod Biol 2014;182:211–5. https://doi.org/10.1016/j.ejogrb.2014.09.033.Search in Google Scholar PubMed
5. Gorsi, B, Hernandez, E, Moore, MB, Moriwaki, M, Chow, CY, Coelho, E, et al.. Causal and candidate gene variants in a large cohort of women with primary ovarian insufficiency. J Clin Endocrinol Metab 2022;107:685–714. https://doi.org/10.1210/clinem/dgab775.Search in Google Scholar PubMed PubMed Central
6. Gordon, CM, Kanaoka, T, Nelson, LM. Update on primary ovarian insufficiency in adolescents. Curr Opin Pediatr 2015;27:511–9. https://doi.org/10.1097/mop.0000000000000236.Search in Google Scholar PubMed
7. Gleicher, N, Darmon, S, Molinari, E, Zhang, L, Hu, J, Albertini, DF, et al.. A form of secondary ovarian insufficiency (SOI) due to adrenal hypoandrogenism a new infertility diagnosis. Endocrine 2021;72:260–7. https://doi.org/10.1007/s12020-020-02512-0.Search in Google Scholar PubMed
8. Van der Stege, JG, Groen, H, van Zadelhoff, SJ, Lambalk, CB, Braat, DD, van Kasteren, YM, et al.. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause 2008;15:23–31. https://doi.org/10.1097/gme.0b013e3180f6108c.Search in Google Scholar PubMed
9. Gleicher, N, Kim, A, Weghofer, A, Kushnir, VA, Shohat-Tal, A, Lazzaroni, E, et al.. Hypoandrogenism associated with diminished functional ovarian reserve. Hum Reprod 2013;28:1084–91. https://doi.org/10.1093/humrep/det033.Search in Google Scholar PubMed
10. Gleicher, N, Kushnir, VA, Weghofer, A, Barad, DH. The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency. Reprod Biol Endocrinol 2016;14:23. https://doi.org/10.1186/s12958-016-0158-9.Search in Google Scholar PubMed PubMed Central
11. Narkwichean, A, Maalouf, W, Baumgarten, M, Polanski, L, Raine-Fenning, N, Campbell, B, et al.. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian aging (DITTO): a proof of principle double-blinded randomized placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol 2017;218:39–48. https://doi.org/10.1016/j.ejogrb.2017.09.006.Search in Google Scholar PubMed
12. Janse, F, Tanahatoe, SJ, Eijkemans, MJ, Fauser, BC. Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis. Hum Reprod Update 2012;18:405–19. https://doi.org/10.1093/humupd/dms013.Search in Google Scholar PubMed
13. Guran, T, Firat, I, Yildiz, F, Kaplan Bulut, I, Dogru, M, Bereket, A. Reference values for serum dehydroepiandrosterone-sulfate in healthy children and adolescents with emphasis on the age of adrenarche and pubarche. Clin Endocrinol 2015;82:712–8. https://doi.org/10.1111/cen.12612.Search in Google Scholar PubMed
14. Büttler, RM, Kruit, A, Blankenstein, MA, Heijboer, AC. Measurement of dehydroepiandrosterone sulfate (DHEAS): a comparison of Isotope-Dilution Liquid Chromatography Tandem Mass Spectrometry (ID-LC-MS/MS) and seven currently available immunoassays. Clin Chim Acta 2013;424:22–6. https://doi.org/10.1016/j.cca.2013.04.028.Search in Google Scholar PubMed
15. Darendeliler, F, Aycan, Z, Kara, C, Özen, S, Eren, E. Çocuk endokrinoloji ve diyabet. 1st ed. Istanbul: Istanbul Medical Press; 2021, vol 2, 2286 pp. ISBN:978-625-7291-22-4.Search in Google Scholar
16. Karaca, Z, Grossman, A, Kelestimur, F. Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis. Rev Endocr Metab Disord 2021;22:179–204. https://doi.org/10.1007/s11154-020-09611-3.Search in Google Scholar PubMed
17. Bornstein, SR, Allolio, B, Arlt, W, Barthel, A, Don-Wauchope, A, Hammer, GD, et al.. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016;101:364–89. https://doi.org/10.1210/jc.2015-1710.Search in Google Scholar PubMed PubMed Central
18. Pluchino, N, Carmignani, A, Cubeddu, A, Santoro, A, Cela, V, Errasti, T. Androgen therapy in women: for whom and when. Arch Gynecol Obstet 2013;288:731–7. https://doi.org/10.1007/s00404-013-2969-7.Search in Google Scholar PubMed
19. Prizant, H, Gleicher, N, Sen, A. Androgen actions in the ovary: balance is key. J Endocrinol 2014;222:R141–51. https://doi.org/10.1530/joe-14-0296.Search in Google Scholar
20. Bachelot, A, Meduri, G, Massin, N, Misrahi, M, Kuttenn, F, Touraine, P. Ovarian steroidogenesis and serum androgen levels in patients with premature ovarian failure. J Clin Endocrinol Metab 2005;90:2391–6. https://doi.org/10.1210/jc.2004-1734.Search in Google Scholar PubMed
21. Bachmann, G, Bancroft, J, Braunstein, G, Burger, H, Davis, S, Dennerstein, L, et al.. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002;77:660–5. https://doi.org/10.1016/s0015-0282(02)02969-2.Search in Google Scholar PubMed
22. Santoro, N, Torrens, J, Crawford, S, Allsworth, JE, Finkelstein, JS, Gold, EB, et al.. Correlates of circulating androgens in mid-life women: the study of women’s health across the nation. J Clin Endocrinol Metab 2005;90:4836–45. https://doi.org/10.1210/jc.2004-2063.Search in Google Scholar PubMed
23. Rosenfield, RL. Normal and premature adrenarche. Endocr Rev 2021;42:783–814. https://doi.org/10.1210/endrev/bnab009.Search in Google Scholar PubMed PubMed Central
24. Yang, JL, Zhang, CP, Li, L, Huang, L, Ji, SY, Lu, CL, et al.. Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis. Endocrinology 2010;151:774–82. https://doi.org/10.1210/en.2009-0751.Search in Google Scholar PubMed
25. Weil, S, Vendola, K, Zhou, J, Bondy, CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951–6. https://doi.org/10.1210/jcem.84.8.5929.Search in Google Scholar PubMed
26. Burger, HG, Dudley, EC, Robertson, DM, Dennerstein, L. Hormonal changes in the menopause transition. Recent Prog Horm Res 2002;57:257–75. https://doi.org/10.1210/rp.57.1.257.Search in Google Scholar PubMed
27. Baranowski, ES, Arlt, W, Idkowiak, J. Monogenic disorders of adrenal steroidogenesis. Horm Res Paediatr 2018;89:292–310. https://doi.org/10.1159/000488034. Epub 2018 Jun 6. PMID: 29874650; PMCID: PMC6067656.Search in Google Scholar PubMed PubMed Central
28. Turcu, A, Smith, JM, Auchus, R, Rainey, WE. Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions. Compr Physiol 2014;4:1369–81. https://doi.org/10.1002/cphy.c140006. PMID: 25428847; PMCID: PMC4437668.Search in Google Scholar PubMed PubMed Central
29. Noordam, C, Dhir, V, McNelis, JC, Schlereth, F, Hanley, NA, Krone, N, et al.. Inactivating PAPSS2 mutations in a patient with premature pubarche. N Engl J Med. 2009;360:2310–8. https://doi.org/10.1056/NEJMoa0810489. Erratum in: N Engl J Med. 2009 Jul 9;3612:217. PMID: 19474428.Search in Google Scholar PubMed
30. Pretorius, E, Arlt, W, Storbeck, KH. A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids. Mol Cell Endocrinol 2017;441:76–85. https://doi.org/10.1016/j.mce.2016.08.014. Epub 2016 Aug 9. PMID: 27519632.Search in Google Scholar PubMed
31. Nanba, AT, Rege, J, Ren, J, Auchus, RJ, Rainey, WE, Turcu, AF. 11-Oxygenated C19 steroids do not decline with age in women. J Clin Endocrinol Metab 2019;104:2615–22. https://doi.org/10.1210/jc.2018-02527. PMID: 30753518; PMCID: PMC6525564.Search in Google Scholar PubMed PubMed Central
32. Imamichi, Y, Yuhki, KI, Orisaka, M, Kitano, T, Mukai, K, Ushikubi, F, et al.. 11-Ketotestosterone is a major androgen produced in human gonads. J Clin Endocrinol Metab 2016;101:3582–91. https://doi.org/10.1210/jc.2016-2311. Epub 2016 Jul 18. PMID: 27428878.Search in Google Scholar PubMed
33. Campana, C, Rege, J, Turcu, AF, Pezzi, V, Gomez-Sanchez, CE, Robins, DM, et al.. Development of a novel cell based androgen screening model. J Steroid Biochem Mol Biol 2016;156:17–22. https://doi.org/10.1016/j.jsbmb.2015.11.005. Epub 2015 Nov 12. PMID: 26581480; PMCID: PMC4748855.Search in Google Scholar PubMed PubMed Central
34. Casson, PR, Lindsay, MS, Pisarska, MD, Carson, SA, Buster, JE. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 2000;15:2129–32. https://doi.org/10.1093/humrep/15.10.2129.Search in Google Scholar PubMed
35. Wylie, K, Rees, M, Hackett, G, Anderson, R, Bouloux, PM, Cust, M, et al.. Androgens, health, and sexuality in women and men. Maturitas 2010;67:275–89. https://doi.org/10.1016/j.maturitas.2010.07.011.Search in Google Scholar PubMed
36. Shifren, JL, Davis, SR, Dennerstein, L, Heiman, JR, Lobo, RA, Simon, JA. The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society. Menopause 2005;12:497–511.10.1097/01.gme.0000177709.65944.b0Search in Google Scholar PubMed
37. Wierman, ME, Basson, R, Davis, SR, Khosla, S, Miller, KK, Rosner, W, et al.. Androgen therapy in women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:3697–710. https://doi.org/10.1210/jc.2006-1121.Search in Google Scholar PubMed
38. Yo, WS, Toh, LM, Brown, SJ, Howe, WD, Henley, DE, Lim, EM. How good is a morning cortisol in predicting an adequate response to intramuscular synacthen stimulation? Clin Endocrinol 2014;81:19–24. https://doi.org/10.1111/cen.12373.Search in Google Scholar PubMed
39. Gravholt, CH, Svenstrup, B, Bennett, P, Sandahl Christiansen, J. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status. Clin Endocrinol 1999;50:791–800. https://doi.org/10.1046/j.1365-2265.1999.00720.x. PMID: 10468952.Search in Google Scholar PubMed
40. Dörr, HG, Penger, T, Marx, M, Rauh, M, Oppelt, PG, Völkl, TKM. Adrenarche and pubarche in girls with turner syndrome during growth-promoting therapy with human growth hormone. BMC Endocr Disord 2019;19:9. https://doi.org/10.1186/s12902-019-0333-z. PMID: 30658614; PMCID: PMC6339350.Search in Google Scholar PubMed PubMed Central
41. Apter, D, Lenko, HL, Perheentupa, J, Söderholm, A, Vihko, R. Subnormal pubertal increases of serum androgens in Turner’s syndrome. Horm Res 1982;16:164–73. https://doi.org/10.1159/000179498. PMID: 6213544.Search in Google Scholar PubMed
42. Viuff, MH, Just, J, Brun, S, Dam, TV, Hansen, M, Melgaard, L, et al.. Women with turner syndrome are both estrogen and androgen deficient: the impact of hormone replacement therapy. J Clin Endocrinol Metab 2022;107:1983–93. https://doi.org/10.1210/clinem/dgac167. PMID: 35302622.Search in Google Scholar PubMed
43. Bakalov, VK, Anasti, JN, Calis, KA, Vanderhoof, VH, Premkumar, A, Chen, S, et al.. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46, XX spontaneous premature ovarian failure. Fertil Steril 2005;84:958–65. https://doi.org/10.1016/j.fertnstert.2005.04.060.Search in Google Scholar PubMed
44. Bornstein, SR, Allolio, B, Arlt, W, Barthel, A, Don-Wauchope, A, Hammer, GD, et al.. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016;101:364–89. https://doi.org/10.1210/jc.2015-1710.Search in Google Scholar PubMed PubMed Central
45. Vogt, EC, Breivik, L, Røyrvik, EC, Grytaas, M, Husebye, ES, Øksnes, M. Primary ovarian insufficiency in women with Addison’s disease. J Clin Endocrinol Metab 2021;106:e2656–63. https://doi.org/10.1210/clinem/dgab140.Search in Google Scholar PubMed PubMed Central
46. Hoyos-Martinez, A, Hoyos, LR, Comkornruecha, M, Diaz, A. Primary ovarian insufficiency in an adolescent population: clinical phenotype and diagnostic approach. J Pediatr Endocrinol Metab 2019;32:979–85. https://doi.org/10.1515/jpem-2019-0083.Search in Google Scholar PubMed
47. Wang, F, Guo, S, Li, P. Two novel mutations in the MCM8 gene shared by two Chinese siblings with primary ovarian insufficiency and short stature. Mol Genet Genomic Med 2020;8:e1396. https://doi.org/10.1002/mgg3.1396.Search in Google Scholar PubMed PubMed Central
48. Qin, Y, Jiao, X, Simpson, JL, Chen, ZJ. Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update 2015;21:787–808. https://doi.org/10.1093/humupd/dmv036.Search in Google Scholar PubMed PubMed Central
© 2024 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Original Articles
- Thyroid surgery in pediatric age: a 10-year experience at a single center and literature review
- Differentiated thyroid cancer in adolescents – does extent of disease at presentation differ with age?
- Evaluation of iodine and selenium level and thyroid functions in patients with cystic fibrosis
- Interpreting positive celiac serology in children with new-onset type 1 diabetes
- Elastographic evaluation for fatty liver disease in north Indian children and adolescents with type 1 diabetes
- Diagnostic value of fasting insulin and insulin-like growth factor-1 levels in girls with central precocious puberty
- Clinical outcomes of switching to lonapegsomatropin from somatropin for treatment of pediatric growth hormone deficiency
- Development of a disease diagnostic model to predict the occurrence of central precocious puberty of female
- Adrenal hypoandrogenism in adolescents with premature ovarian insufficiency
- The clinical presentation and genetic diagnosis of Tangier disease in the pediatric age group
- Clinical and genetic diagnosis of first cohort of differences of sexual development in the Iranian population
- Short Communication
- Effect of a GnRH injection on kisspeptin levels in girls with suspected precocious puberty: a randomized-controlled pilot study
- Case Reports
- Coexistence of phenylketonuria and tyrosinemia type 3: challenges in the dietary management
- Acrodermatitis dysmetabolica: lessons from two pediatric cases
- Dramatic response to Evinacumab in a North Indian girl with homozygous familial hypercholesterolemia
Articles in the same Issue
- Frontmatter
- Original Articles
- Thyroid surgery in pediatric age: a 10-year experience at a single center and literature review
- Differentiated thyroid cancer in adolescents – does extent of disease at presentation differ with age?
- Evaluation of iodine and selenium level and thyroid functions in patients with cystic fibrosis
- Interpreting positive celiac serology in children with new-onset type 1 diabetes
- Elastographic evaluation for fatty liver disease in north Indian children and adolescents with type 1 diabetes
- Diagnostic value of fasting insulin and insulin-like growth factor-1 levels in girls with central precocious puberty
- Clinical outcomes of switching to lonapegsomatropin from somatropin for treatment of pediatric growth hormone deficiency
- Development of a disease diagnostic model to predict the occurrence of central precocious puberty of female
- Adrenal hypoandrogenism in adolescents with premature ovarian insufficiency
- The clinical presentation and genetic diagnosis of Tangier disease in the pediatric age group
- Clinical and genetic diagnosis of first cohort of differences of sexual development in the Iranian population
- Short Communication
- Effect of a GnRH injection on kisspeptin levels in girls with suspected precocious puberty: a randomized-controlled pilot study
- Case Reports
- Coexistence of phenylketonuria and tyrosinemia type 3: challenges in the dietary management
- Acrodermatitis dysmetabolica: lessons from two pediatric cases
- Dramatic response to Evinacumab in a North Indian girl with homozygous familial hypercholesterolemia